台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    86.3
  • 漲跌
    ▲2.4
  • 漲幅
    +2.86%
  • 成交量
    580
  • 產業
    上櫃 生技醫療類股
  • 317人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
中裕 (4147)籌碼相關-元大-復北 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-復北 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/231185.09184.7082.90106121.63%
2024/12/19182.6000.0082.5016150.16%
2024/12/161.181.5000.0081.801.16310.17%
2024/12/132.183.9100.0083.002.16270.33%
2024/12/120.185.4500.0085.100.16240.02%
2024/12/104.389.1500.0087.504.36150.69%
2024/12/09887.811190.0890.10-3600-0.50%
2024/12/06489.40988.4787.60-5573-0.87%
2024/12/02384.3700.0084.2035240.57%
2024/11/2900.00184.3084.30-1524-0.19%
2024/11/28182.0000.0082.0015340.19%
2024/11/2500.00184.5085.00-1543-0.18%
2024/11/13281.9000.0081.7025370.37%
2024/11/01482.4000.0082.8046060.66%
2024/10/2900.00181.0080.90-1588-0.17%
2024/10/28182.601.782.5981.00-0.6584-0.11%
2024/10/24080.8000.0080.8005720.00%
2024/10/2200.006.178.9680.60-6.1562-1.08%
2024/10/1700.000.375.1075.00-0.3591-0.05%
2024/10/14674.3000.0074.0066140.98%
2024/10/04178.6000.0078.2016290.16%
2024/09/26181.5000.0080.2016500.15%
2024/09/250.983.40183.5082.20-0.1651-0.01%
2024/09/19180.5000.0080.7016480.15%
2024/09/04282.20181.4081.3017420.13%
2024/08/3000.00185.5086.40-1750-0.13%
2024/08/2700.00182.2082.00-1739-0.14%
2024/08/19579.7000.0079.4057520.66%
2024/08/16579.9000.0080.9057530.66%
2024/08/0900.00178.0078.40-1785-0.13%
2024/08/08077.00376.7376.70-3783-0.38%
2024/08/0700.00675.5075.60-6779-0.77%
2024/08/05277.40176.2074.0017340.14%
2024/07/31282.6000.0082.6027320.27%
2024/07/29183.9000.0082.6017410.13%
2024/07/22288.95290.2587.1007450.00%
2024/07/19186.5000.0086.5017270.14%
2024/07/18187.5000.0088.4017090.14%
2024/07/171088.0700.0088.10107131.40%
2024/07/1500.00186.0086.30-1747-0.13%
2024/07/12885.3015784.3485.30-149757-19.68% 大賣/鉅額交易
2024/07/1000.00184.9085.80-1783-0.13%
2024/07/09584.0000.0084.1058100.62%
2024/07/0500.00187.1086.80-1856-0.12%
2024/07/04586.7000.0086.9058890.56%
2024/06/2800.00189.3089.30-11,103-0.09%
2024/06/27289.9500.0089.4021,1190.18%
2024/06/24987.0100.0086.7091,1280.80%
2024/06/21588.5000.0088.9051,1210.45%
2024/06/2000.00289.7089.90-21,128-0.18%
2024/06/11791.13693.5091.0011,1820.08%
2024/05/30588.6800.0088.6051,4750.34%
2024/05/29189.8000.0089.1011,5110.07%
2024/05/2700.00087.4087.5001,7010.00%
2024/05/21188.0100.0088.0012,1230.05%
2024/05/1700.00188.0087.70-12,170-0.05%
2024/05/08186.000.186.8586.700.92,3350.04%
2024/05/0600.00088.4088.0002,3310.00%
2024/04/2900.00185.5086.00-12,338-0.04%
2024/04/17188.5000.0087.8012,3560.04%
2024/04/160.787.6000.0087.900.72,3510.03%
2024/04/15491.3000.0090.1042,3420.17%
2024/04/12094.4300.0094.0002,3390.00%
2024/04/0900.00595.3096.20-52,301-0.22%
2024/04/08290.7200.0093.0022,2360.09%
2024/04/03890.85390.8090.6052,1950.23%
2024/04/0100.00291.0090.10-22,074-0.10%
2024/03/22388.7000.0088.8032,0200.15%
2024/03/2100.00188.8088.60-12,014-0.05%
2024/03/201189.70089.7089.40112,0020.55%
2024/03/192991.5800.0091.10291,9881.46%
2024/03/182090.2000.0091.30201,9811.01%
2024/03/12591.80091.8091.9051,9440.26%
2024/03/11194.50194.0094.1001,9070.00%
2024/03/08596.8000.0096.8051,8650.27%
2024/03/071104.501107.00107.5001,7970.00%
2024/03/051105.501103.50102.5001,7040.00%
2024/03/0400.001109.00109.00-11,641-0.06%
2024/02/2910110.301110.00110.5091,5590.58%
2024/02/276113.4211114.55114.00-51,413-0.35%
2024/02/263.2105.811108.50108.002.21,2470.18%
2024/02/230103.507103.64102.50-71,107-0.63%
2024/02/2200.00396.3096.30-31,019-0.29%
2024/02/21095.2300.0094.8001,0050.00%
2024/02/2000.001693.7896.30-16979-1.63%
2024/02/19192.7100.0093.0019520.11%
2024/02/161092.9800.0091.60109521.05%
2024/02/15191.00192.0091.1009630.00%
2024/02/0500.00189.0088.70-1978-0.10%
2024/02/0100.00491.1091.50-4985-0.41%
2024/01/2400.00187.5088.90-1991-0.10%
2024/01/2200.00085.6085.1001,0070.00%
2024/01/19085.6000.0085.7001,0590.00%
2024/01/1800.000.785.2085.50-0.71,061-0.06%
2024/01/17186.3000.0085.8011,0660.09%
2024/01/1200.00490.6589.10-41,055-0.38%
2024/01/08188.001188.0287.20-101,011-0.99%
2024/01/0500.00187.3087.10-1996-0.10%
2024/01/04185.6000.0085.2019560.11%
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕與沙國藥廠簽抗愛滋病新藥中東、北非獨家銷售合約UDN聯合新聞網-2024/03/14
中裕 相關文章